Records 1 - 30
| PIK3CA mutation status, progression and survival in advanced HR?+?/HER2- breast cancer: a meta-analysis of published clinical trials.
BMC cancer 2022 Sep 22 (1): 1002.
Fillbrunn Mirko, Signorovitch James, André Fabrice, Wang Iris, Lorenzo Ines, Ridolfi Antonia, Park Jinhee, Dua Akanksha, Rugo Hope
| Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer.
Targeted oncology 2022 Jun .
Tan Elaine S, Fan Wenyi, Knepper Todd C, Schell Michael J, Sahin Ibrahim H, Fleming Jason B, Xie H
| Systematic Review and Meta-analysis of the Most Common Genetic Mutations in Esophageal Squamous Cell Carcinoma.
Journal of gastrointestinal cancer 2021 Oct .
Naseri Amirreza, Salehi-Pourmehr Hanieh, Majidazar Reza, Seraji Parya, Rezazadeh-Gavgani Erfan, Zehtabi Mojtaba, Kiani-Kezbin Hamed, Salehnia Fatemeh, Hassannezhad Sina, Hajikamanj Arash, Raeisi Morta
| Driver and novel genes correlated with metastasis of non-small cell lung cancer: A comprehensive analysis.
Pathology, research and practice 2021 Jul 224 153551.
Wu Yongfeng, Ni Heng, Yang Dexin, Niu Yuequn, Chen Kelie, Xu Jinming, Wang Fang, Tang Song, Shi Yu, Zhang Honghe, Hu Jian, Xia Dajing, Wu Yih
| Worldwide prevalence of PI3K-AKT-mTOR pathway mutations in head and neck cancer: A systematic review and meta-analysis.
Critical reviews in oncology/hematology 2021 Mar 160 103284.
Moura Adriana Castelo de, Assad Daniele Xavier, Amorim Dos Santos Juliana, Porto de Toledo Isabela, Barra Gustavo Barcelos, Castilho Rogerio Moraes, Squarize Cristiane Helena, Guerra Eliete Neves Sil
| PIK3CA Mutations and Their Impact on Survival Outcomes of Patients with Cervical Cancer: A Systematic Review.
Acta cytologica 2020 Jul 1-9.
Pergialiotis Vasilios, Nikolaou Christina, Haidopoulos Dimitrios, Frountzas Maximos, Thomakos Nikolaos, Bellos Ioannis, Papapanagiotou Angeliki, Rodolakis Alexandr
| Prognostic impact of PIK3CA protein expression in triple negative breast cancer and its subtypes.
Journal of cancer research and clinical oncology 2019 Jul .
Elfgen C, Reeve K, Moskovszky L, Güth U, Bjelic-Radisic V, Fleisch M, Tausch C, Varga
| Associations of PIK3CA mutations with clinical features and prognosis in gastric cancer.
Future oncology (London, England) 2019 Mar .
Shen Xiaobing, Zhao Ying, Chen Xiaowei, Sun Haixiang, Liu Mengqi, Zhang Wenwen, Jiang Fei, Li Pengf
| Liquid biopsy prediction of axillary lymph node metastasis, cancer recurrence, and patient survival in breast cancer: A meta-analysis.
Medicine 2018 Oct 97 (42): e12862.
Lee Ju-Han, Jeong Hoiseon, Choi Jung-Woo, Oh Hwa Eun, Kim Young-S
| PIK3CA mutations and their response to neoadjuvant treatment in early breast cancer: A systematic review and meta-analysis.
Thoracic cancer 2018 Mar .
Fan Hongwei, Li Chao, Xiang Qian, Xu Ling, Zhang Zhuo, Liu Qianxin, Zhang Tonttong, Zhou Ying, Zhao Xia, Cui Yim
| Association between PD-L1 expression and driver gene status in non-small-cell lung cancer: a meta-analysis.
Oncotarget 2018 Jan 9 (7): 7684-7699.
Lan Bo, Ma Chengxi, Zhang Chengyan, Chai Shoujie, Wang Pingli, Ding Liren, Wang K
| Mutations of key driver genes in colorectal cancer progression and metastasis.
Cancer metastasis reviews 2018 Jan .
Huang Dongdong, Sun Wenjie, Zhou Yuwei, Li Peiwei, Chen Fang, Chen Hanwen, Xia Dajing, Xu Enping, Lai Maode, Wu Yihua, Zhang Hong
| Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy.
World journal of gastroenterology 2016 Aug 22 (30): 6944-54.
Lo Nigro Cristiana, Ricci Vincenzo, Vivenza Daniela, Granetto Cristina, Fabozzi Teresa, Miraglio Emanuela, Merlano Marco
| Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2016 Jul .
Mei Z, Duan C, Li C, Cui L, Ogino
| Diagnostic Accuracy of PIK3CA Mutation Detection by Circulating Free DNA in Breast Cancer: A Meta-Analysis of Diagnostic Test Accuracy.
PloS one 2016 11 (6): e0158143.
Zhou Yidong, Wang Changjun, Zhu Hanjiang, Lin Yan, Pan Bo, Zhang Xiaohui, Huang Xin, Xu Qianqian, Xu Yali, Sun Qia
| PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2015 Dec .
Paleari L, Puntoni M, Clavarezza M, DeCensi M, Cuzick J, DeCensi
| The predictive and prognostic role of phosphatase phosphoinositol-3 (PI3) kinase (PIK3CA) mutation in HER2-positive breast cancer receiving HER2-targeted therapy: a meta-analysis.
Breast cancer research and treatment 2015 Aug 152 (3): 463-76.
Ibrahim Ezzeldin M, Kazkaz Ghieth A, Al-Mansour Mubarak M, Al-Foheidi Meteb
| Predictive value of K-ras and PIK3CA in non-small cell lung cancer patients treated with EGFR-TKIs: a systemic review and meta-analysis.
Cancer biology & medicine 2015 Jun 12 (2): 126-39.
Chen Jie-Ying, Cheng Ya-Nan, Han Lei, Wei Feng, Yu Wen-Wen, Zhang Xin-Wei, Cao Shui, Yu Jin-
| A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Apr 26 (4): 624-44.
Findlay J M, Middleton M R, Tomlinson
| The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis.
Acta oncologica (Stockholm, Sweden) 2014 Jul 53 (7): 852-64.
Therkildsen Christina, Bergmann Troels K, Henrichsen-Schnack Tine, Ladelund Steen, Nilbert M
| Phosphatidylinositol-3-kinase pathway aberrations in gastric and colorectal cancer: meta-analysis, co-occurrence and ethnic variation.
International journal of cancer. Journal international du cancer 2014 Mar 134 (5): 1232-8.
Chong Mei-Ling, Loh Marie, Thakkar Bhavin, Pang Brendan, Iacopetta Barry, Soong Rich
| Anti-epidermal growth factor receptor monoclonal antibody-based therapy for metastatic colorectal cancer: a meta-analysis of the effect of PIK3CA mutations in KRAS wild-type patients.
Archives of medical science : AMS 2014 Feb 10 (1): 1-9.
Huang Lulu, Liu Zhenfang, Deng Donghong, Tan Aihua, Liao Ming, Mo Zengnan, Yang Xiao
| PIK3CA mutations define favorable prognostic biomarkers in operable breast cancer: a systematic review and meta-analysis.
OncoTargets and therapy 2014 7 543-52.
Liu Yi-Rong, Jiang Yi-Zhou, Zuo Wen-Jia, Yu Ke-Da, Shao Zhi-Mi
| Prognostic role of PIK3CA mutations and their association with hormone receptor expression in breast cancer: a meta-analysis.
Scientific reports 2014 4 6255.
Pang Bo, Cheng Shi, Sun Shi-Peng, An Cheng, Liu Zhi-Yuan, Feng Xue, Liu Gui-Ji
| The predictive role of phosphatase and tensin homolog (PTEN) loss, phosphoinositol-3 (PI3) kinase (PIK3CA) mutation, and PI3K pathway activation in sensitivity to trastuzumab in HER2-positive breast cancer: a meta-analysis.
Current medical research and opinion 2013 Jun 29 (6): 633-42.
Wang Yaohui, Liu Yu, Du Yueyao, Yin Wenjin, Lu Jinso
| Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013 May 22 (5): 827-34.
Park Jong Y, Amankwah Ernest K, Anic Gabriella M, Lin Hui-Yi, Walls Brooke, Park Hyun, Krebs Kevin, Madden Melissa, Maddox Kristen, Marzban Suroosh, Fang Shenying, Chen Wei, Lee Jeffrey E, Wei Qingyi, Amos Christopher I, Messina Jane L, Sondak Vernon K, Sellers Thomas A, Egan Kathleen
| PIK3CA mutation is associated with poor survival among patients with metastatic colorectal cancer following anti-EGFR monoclonal antibody therapy: a meta-analysis.
Journal of cancer research and clinical oncology 2013 May 139 (5): 891-900.
Wu Shuangjie, Gan Yu, Wang Xinhai, Liu Jun, Li Mengjun, Tang Yif
| Promising biomarkers for predicting the outcomes of patients with KRAS wild-type metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: a systematic review with meta-analysis.
International journal of cancer. Journal international du cancer 2013 Mar .
Yang ZY, Wu XY, Huang YF, Di MY, Zheng DY, Chen JZ, Ding H, Mao C, Tang JL
| PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012 Jun 23 (6): 1518-25.
Mao C, Yang Z Y, Hu X F, Chen Q, Tang J
| Assessing the potential value of long interspersed element-1 hypomethylation in colorectal cancer: evidence from retrospective studies.
OncoTargets and therapy 0 8 3265-3276.
Tang Jie-Ting, Wang Zhen-Hua, Fang Jing-Yu